Wilson Greatbatch Technologies, Inc.

Wilson Greatbatch Ltd.

Noelle M Waite

Esther S Takeuchi

Kenneth C Syracuse

Hong Gan

It is known that reforming implantable defibrillator capacitors at least partially restores and preserves their charging efficiency. An industry-recognized standard is to reform implantable capacitors by pulse discharging the connected electrochemical cell about once every three months throughout the useful life of the medical device. A Li/SVO cell typically powers such devices. The present invention relates to methodologies for significantly minimizing, if not entirely eliminating, the occurrence of voltage delay and irreversible Rdc growth in the about 35 % to 70 % DOD region by subjecting Li/SVO cells to novel discharge regimes. At the same time, the connected capacitors in the cardiac defibrillator are reformed to maintain them at their rated breakdown voltages.

Discharge methodologies for lithium/silver vanadium oxide cells to manage voltage delay and permanent RDC growth region

The present invention is directed to a method for analyzing the tail-end behavior of a lithium cell having a solid cathode. The tail of a longer-term accelerated discharge data (ADD) test is estimated from the tail of two shorter-term ADD tests. This is accomplished by first comparing the discharge tails of shorter-term ADD tests and determining angles or rotation that correspond to Rdc growth, and then trending rotation angles versus time to reach a give DoD. For example, the 18-month and 36-month ADD test tails are used to estimate the ADD test tail of a similarly constructed cell subjected to a longer-term ADD test, for example a 48-month ADD test.

Method for estimating long term end-of-life characteristics using short-term data for lithium/silver vanadium oxide cells

It is known that reforming implantable defibrillator capacitors at least partially restores and preserves their charging efficiency. An industry-recognized standard is to reform implantable capacitors by pulse discharging the connected electrochemical cell about once every three months throughout the useful life of the medical device. A Li/SVO cell typically powers such devices. The present invention relates to methodologies for accurately determining the precise boundaries of voltage delay and irreversible Rdc growth region in the about 25% to 70% DOD region so that more frequent pulse discharging for the purpose of cell reform is confined to the limits of the region. At the same time, the connected capacitors in the cardiac defibrillator are reformed to maintain them at their rated breakdown voltages.

Methods to improve efficiency of lithium/silver vanadium oxide cell discharge energy in implantable medical device applications

It is known that reforming implantable defibrillator capacitors at least partially restores and preserves their charging efficiency. An industry-recognized standard is to reform implantable capacitors by pulse discharging the connected electrochemical cell about once every three months throughout the useful life of the medical device. A Li/SVO cell typically powers such devices. The present invention relates to methodologies for significantly minimizing, if not entirely eliminating, the occurrence of voltage delay and irreversible Rdc growth in the about 25% to 70% DOD region by subjecting Li/SVO cells to novel discharge regimes. At the same time, the connected capacitors in the cardiac defibrillator are reformed to maintain them at their rated breakdown voltages.

Discharge methodologies for optimizing the performance of lithium/silver vanadium oxide cells

A &ldquo;fuel gauge&rdquo; for a pulse dischargeable alkali metal/solid cathode cell is described. The rate of voltage recovery is used to determine the state of charge of the cell. Voltage recovery includes recovery from one load to a second, lighter load, or a loaded condition to OCV. The present invention is particularly useful as an end-of-life indicator for a Li/CF cell powering an implantable medical device.

Fuel gauge for an alkali metal electrochemical cell

A 'fuel gauge' for a pulse dischargeable alkali metal/solid cathode cell is described. The rate of voltage recovery is used to determine the state of charge of the cell. Voltage recovery includes recovery from one load to a second, lighter load, or a loaded condition to OCV. The present invention is particularly useful as an end-of-life indicator for a Li/CF.sub.x cell powering an implantable medical device.

Growing community of inventors

Clarence Center, NY, United States of America

Noelle M Waite